However, it is noteworthy that PAX2 was found to be reactivated in renal cell carcinoma and that around 90% of renal cell carcinoma patients have high PAX2 and PAX8 expression levels [5,15]. This evidence concerns the gene PAX8 and renal cell carcinoma.